Maher Masoud

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ David Sandoval, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maher Masoud:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. President and CEO, Director Common Stock 175K $240K $1.37 Aug 13, 2025 Direct
MAXCYTE, INC. President and CEO, Director Employee Stock Option (right to buy) 348K Mar 14, 2025 Direct

Insider Reports Filed by Maher Masoud

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MXCT MAXCYTE, INC. Aug 13, 2025 1 $103K 4 Aug 13, 2025 President and CEO, Director
MXCT MAXCYTE, INC. Mar 14, 2025 1 $0 4 Mar 18, 2025 President and CEO, Director
MXCT MAXCYTE, INC. Jun 7, 2024 2 $489K 4 Jun 10, 2024 President and CEO, Director
MXCT MAXCYTE, INC. Jan 3, 2024 1 $0 4 Jan 4, 2024 President and CEO, Director
MXCT MAXCYTE, INC. Mar 20, 2023 1 $0 4 Mar 21, 2023 EVP and General Counsel
MXCT MAXCYTE, INC. Mar 25, 2022 1 $0 4 Mar 29, 2022 EVP and General Counsel
MXCT MAXCYTE, INC. Nov 12, 2021 11 -$738K 4 Nov 16, 2021 EVP and General Counsel
MXCT MAXCYTE, INC. Aug 9, 2021 1 $0 4 Aug 11, 2021 EVP and General Counsel
MXCT MAXCYTE, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 EVP and General Counsel